COVID-19 Testing: More details
COVID-19 Resources: More details
ImmuniMed Inc. is an innovative, clinical-stage, Research & Development Biopharmaceutical Company. ImmuniMed Inc. develops oral antibody therapy using passive vaccination to treat and prevent gastro-enteric infections. Their technology is designed to utilize chicken eggs as bioreactors to manufacture specific polyclonal antibodies – a new class of biopharmaceuticals.
member
Individuals who currently have a digital Manitoba immunization card or are applying for one can visit immunizationcard.Manitoba.ca or call 1-844-MAN-VACC (1-844-626-8222) to request their PVC, in digital or hard copy.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.